MetaCap

Coherus Oncology (CHRS) Stock Chart

NASDAQ: CHRSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.01-0.02 (-1.94%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

CHRS technical summary

CHRS is trading 22.1% below its 50-day simple moving average of $1.30 and 35.6% below its 200-day average of $1.57. The 50-day average is below the 200-day average, a configuration technical analysts associate with a longer-term downtrend. The 14-day Relative Strength Index (RSI) is 32.4, within the neutral 30 to 70 band.

Over the past year, the stock ranged from $1.01 (Oct 6, 2026) to $2.62 (Jan 27, 2026); the current price is at the bottom of that range. Annualized 30-day volatility is 72.2%. Based on the last session's high, low and close, the classic pivot point is $1.03, with first resistance at $1.06 and first support at $0.9867.

These indicators describe past price behavior for Coherus Oncology; they are not predictions.

Summary generated from market data by MetaCap's automated system. Methodology

Technical indicators

Beta
—
1Y high
2.62 (Jan 27)
1Y low
1.01 (Oct 6)
Last close
1.01

CHRS price performance

1 week

-16.53%

1 month

-26.28%

3 months

-38.79%

6 months

-40.59%

Year to date

-28.87%

1 year

-40.94%

3 years

-73.49%

5 years

-94.06%

CHRS price return, excluding dividends.

Moving averages

Simple and exponential moving averages
PeriodSimple (SMA)Exponential (EMA)
5-day1.10Price below1.08Price below
10-day1.13Price below1.13Price below
20-day1.22Price below1.20Price below
50-day1.30Price below1.29Price below
100-day1.39Price below1.38Price below
200-day1.57Price below1.48Price below

Moving averages are computed from daily closing prices over the past year. What is a moving average?

Pivot points

Classic pivot points
LevelPrice
Resistance 3 (R3)1.13
Resistance 2 (R2)1.10
Resistance 1 (R1)1.06
Pivot point1.03
Support 1 (S1)0.9867
Support 2 (S2)0.9633
Support 3 (S3)0.9167

Classic floor-trader pivots from the last session's high, low and close. How pivot points work

Learn technical analysis